Drug firm Bafna Pharmaceuticals Ltd said it has received approval from UK Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture Finasteride, used in the treatment of enlarged prostate gland.
The company will manufacture Finasteride in 5mg dosage, Bafna Pharmaceuticals said in a statement.
The approval from UK MHRA for Finasteride 5mg will enable the company to widen the customer base in Europe.
Finasteride 5mg tablet is a prescription-only medicine used for the treatment and control of benign prostatic hyperplasia in order to cause regression of an enlarged prostate and improvement of other symptoms.
On Monday, Bafna Pharma rose 1.59% to Rs47.80 on the Bombay Stock Exchange, while the benchmark Sensex closed 1.90% up at 19,957.59 points.
Inside story of the National Stock Exchange’s amazing success, leading to hubris, regulatory capture and algo scam
Fiercely independent and pro-consumer information on personal finance.
1-year online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
30-day online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
Complete access to Moneylife archives since inception ( till the date of your subscription )
